title: Successful use of dapsone in refractory pregnancy-associated idiopathic thrombocytopenic purpura.
authors.forename: R
authors.initials: R
authors.lastname: Lush
authors.forename: H
authors.initials: H
authors.lastname: Iland
authors.forename: B
authors.initials: B
authors.lastname: Peat
authors.forename: G
authors.initials: G
authors.lastname: Young
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D013156:Splenectomy; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D003622:Dapsone; D011241:Prednisone